Vasculogenic mimicry (VM) formation by cancer cells is known to play a crucial role in tumor progression, whereas the detailed mechanism of which has been unclear. In this study, we focused on integrin β1 (ITGB1) and assessed the role of ITGB1 on VM formation. We used in vitro methods to seed cancer cells on Matrigel to evaluate the capability of VM formation. We performed ITGB1 gene deletion by using the CRISPR/Cas9 system and these ITGB1‐knockout cells did not exhibit the VM‐like network formation. Further, re‐introduction of ITGB1 rescued VM‐like network formation in ITGB1‐knockout cells. In conclusion, ITGB1 is a critical factor on VM in human cancer cells and inhibition of ITGB1 may be a novel therapeutic approach for malignant cancer.
R-spondin1 (Rspo1) is a secreted protein that enhances Wnt signaling, which has crucial functions in embryonic development and several cancers. C-mannosylation is a rare type of glycosylation and might regulate secretion, protein–protein interactions, and enzymatic activity. Although human Rspo1 contains 2 predicted C-mannosylation sites, C-mannosylation of Rspo1 has not been reported, nor have its functional effects on this protein. In this study, we demonstrate by mass spectrometry that Rspo1 is C-mannosylated at W153and W156. Using Lec15.2 cells, which lack dolichol-phosphate-mannose synthesis activity, and mutant Rspo1-expressing cells that replace W153and W156by alanine residues, we observed that C-mannosylation of Rspo1 is required for its secretion. Further, the enhancement of canonical Wnt signaling by Rspo1 is regulated by C-mannosylation. Recently DPY19 was reported to be a C-mannosyltransferase in Caenorhabditis elegans, but no C-mannosyltransferases have been identified in any other organism. In gain- and loss-of-function experiments, human DPY19L3 selectively modified Rspo1 at W156but not W153based on mass spectrometry. Moreover, knockdown of DPY19L3 inhibited the secretion of Rspo1. In conclusion, we identified DPY19L3 as the C-mannosyltransferase of Rspo1 at W156and found that DPY19L3-mediated C-mannosylation of Rspo1 at W156is required for its secretion.
1 December 2015 in Biochemical and Biophysical Research Communications
Macroautophagy is a cellular response that leads to the bulk, non-specific degradation of cytosolic components, including organelles. In recent years, it has been recognized that autophagy is essential for prevention of neurodegenerative diseases, including Parkinson disease (PD) and Huntington disease (HD). Here, we show that conophylline (CNP), a vinca alkaloid, induces autophagy in an mTOR-independent manner. Using a cellular model of PD, CNP suppressed protein aggregation and protected cells from cell death caused by treatment with 1-methyl-4-phenylpyridinium (MPP+), a neuro-toxin, by inducing autophagy. Moreover, in the HD model, CNP also eliminated mutant huntingtin aggregates. Our findings demonstrate the possible use of CNP as a therapeutic drug for neurodegenerative disorders, including PD and HD.
Hyaluronidase1 (HYAL1) is a hydrolytic enzyme that degrades hyaluronic acid (HA) and has three predicted N‐glycosylation sites at Asn99, Asn216, and Asn350. In this report, we show the functional significance of N‐glycosylation on HYAL1 functions. Using mass spectrometry, we demonstrated that HYAL1 was N‐glycosylated at the three asparagine residues. N‐glycosylation of HYAL1 is important for secretion of HYAL1, as demonstrated by site‐directed mutation. Moreover, a defect of N‐glycosylation attenuated the enzymatic activity of HYAL1. Thus, HYAL1 is N‐glycosylated at the three asparagine residues, and its secretion and enzymatic activity are regulated by N‐glycosylation.
R‐spondin3 (Rspo3) is a secreted protein, which acts as an agonist of canonical Wnt/β‐catenin signaling that plays an important role in embryonic development and homeostasis. In this study, we focused on C‐mannosylation, a unique type of glycosylation, of human Rspo3. Rspo3 has two putative C‐mannosylation sites at Trp153 and Trp156; however, it had been unclear whether these sites are C‐mannosylated or not. We demonstrated that Rspo3 was C‐mannosylated at both Trp153 and Trp156 by mass spectrometry. Using C‐mannosylation‐defective Rspo3 mutant‐overexpressing cell lines, we found that C‐mannosylation of Rspo3 promotes its secretion and activates Wnt/β‐catenin signaling.